Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with Parkinson's disease according to a specific set of medical criteria (known as the Gelb et al. criteria)
- People who have already had genetic testing for Parkinson's disease
- People whose score on a standard memory and thinking test called the Montreal Cognitive Assessment (MoCA) falls within a specific range (a raw score between 15.50 and 22.23), which generally reflects mild thinking or memory changes
- People who have signed a consent form and privacy agreement agreeing to take part
- People who are already participating in a cognitive stimulation program as part of their regular care
Who may not be able to join:
- People who were initially thought to have Parkinson's disease but were later found to have a different condition during further testing
- People who have declined to give consent to participate in the study
- People who have a Parkinson's disease diagnosis along with a level of cognitive decline that meets the criteria for dementia
- People who are receiving a treatment called deep brain stimulation (a surgical procedure involving a device implanted in the brain to help control movement symptoms), as this treatment may affect thinking and memory in ways that could interfere with the study results
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390255033621
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Efficacy of the cognitive training on cognitive function in PD patients with GBA mutation compared to a control group of PD patients without genetic mutations.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.